2012 Big Money Shift Opportunity #2: It’s Crushing Deadly “Terminator” Cancer
Nobel Prize-winner James Watson – famous for his co-discovery of DNA – flat out predicts that we will develop a cure for cancer within the next ten years.
And one thing’s for certain: Whenever this glorious day arrives, it sure won’t be thanks to chemo and radiation.
“If we are ever going to use the word ‘cure’, the immune system is going to have to come into play,” says Stephen Hodi, Director of the Melanoma Center at Dana-Farber Cancer Institute in Boston.
He’s talking about immunotherapy-based drugs that work completely different than traditional chemotherapy and radiation treatments.
Chemo basically poisons the body, including the cancer cells, which is why the side effects can be so severe. On the other hand, immunotherapeutic drugs use the body’s own immune system to kill the cancer.
Already, “first generation” immunotherapy drugs (“monoclonal antibodies”) including Herceptin, Rituxan and Erbitux have done $15 billion in sales.
But with over 12 million new cancer patients each year, more effective treatments are desperately needed.
And there’s one cancer-killer that’s positioned to crush the disease…
How to Play Immunotherpay for Potential 1,000% Gains:
This breakthrough vaccine attacks the most common brain cancer known as “GBM”. Normally, this tumor is so powerful, one typically reserved medical report labels it “The Terminator.”
Sadly, most diagnosed with it have just months, even weeks, to live.
The current most popular treatment for brain cancer only extends a patient’s life by about 14 months. And it brings in over $1 billion per year.
However, in clinical trials, with this new treatment, many patients are now living far longer… some as much as five years.
When this new drug hits the market – which I believe could happen very soon – it’s likely to blow the competition out of the water.
The drug passed Phase II trials with flying colors and is already into Phase III… and only one company owns the rights to it.
If we see more of the same results in the Phase III trials, then forget blockbuster… we’re talking mega-blockbuster here.
That could mean potential gains of over 1,000% in the next 12 to 24 months.
I’ve got more information to share with you on this opportunity. But here’s something that might even be more lucrative.
Page 5
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9
[cfsp name="joinnow"]